Transcriptomic changes in mouse embryonic stem cells exposed to thalidomide during spontaneous differentiation.

Data Brief

Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD, USA.

Published: September 2015

Thalidomide is a potent developmental toxicant that induces a range of birth defects, notably severe limb malformations. To unravel the molecular mechanisms underpinning the teratogenic effects of thalidomide, we used microarrays to study transcriptomic changes induced by thalidomide in an in vitro model based on the differentiation of mouse embryonic stem cells (mESCs), and published the major findings in a research article entitled "Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells" [1]. The data presented herein contains complementary information related to the aforementioned research article.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510476PMC
http://dx.doi.org/10.1016/j.dib.2015.05.014DOI Listing

Publication Analysis

Top Keywords

mouse embryonic
12
embryonic stem
12
transcriptomic changes
8
stem cells
8
changes mouse
4
cells exposed
4
thalidomide
4
exposed thalidomide
4
thalidomide spontaneous
4
spontaneous differentiation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!